DexCom, Inc. (DXCM) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $80.26 -6.39%
EPS Growth %: +9.8%
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: +9.8%
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
DexCom, Inc. (NASDAQ: DXCM) reported Q2 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $21.4 million versus the consensus estimate of $20.83 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- Reliance Steel (RS) Tops Q3 EPS by 122c; offers outlook
- Medpace beats Q3 estimates but guides below on revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
